Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | KDR | P35968 | 1/20 | 0.60 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.59 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.59 |
| ▸ | GRM4 | Q14833 | 5/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | CASP3 | P42574 | 1/20 | 0.53 |
| ▸ | JAK2 | O60674 | 1/20 | 0.51 |
| ▸ | TYK2 | P29597 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6018724 | 0.88 | TDP1 (0.70) | HPGDKDRPABPC1EIF4HMAPT | |
| SCHEMBL28555588 | 0.81 | KDR (0.57) | HPGDKDRGRM4NPC1RAB9A | |
| SCHEMBL1018130 | 0.80 | SMO (0.71) | GRM4MAPT | |
| SCHEMBL12214921 | 0.80 | GRM4 (0.62) | GRM4MAPT | |
| SCHEMBL9867402 | 0.80 | KDR (0.70) | HPGDCYP1A2CYP2C19KDRPABPC1 | |
| SCHEMBL6019417 | 0.80 | KDM4E (0.52) | HPGDMAPTTDP1NPC1RAB9A | |
| SCHEMBL10772697 | 0.77 | HDAC3 (0.45) | CYP1A2MAPTNPC1RAB9AALDH1A1 | |
| SCHEMBL27508370 | 0.77 | CHRNB2 (0.45) | CYP1A2MAPTNPC1RAB9AALDH1A1 | |
| SCHEMBL6020308 | 0.76 | MAPK1 (0.66) | HPGDNPC1RAB9AALDH1A1LMNA | |
| SCHEMBL5225094 | 0.76 | KMT2A (0.69) | HPGDGRM4TDP1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060178513-A1 | Pyridinylanilides | BAYER CROPSCIENCE AG (DE) | 2006-08-10 | — | — | US | disclosed |
| EP-1656020-A2 | PYRIDINYLANILIDES | Bayer CropScience AG (DE) | 2006-05-17 | — | — | EP | disclosed |
| WO-2005004606-A2 | PYRIDINYLANILIDES | BAYER CROPSCIENCE AG (DE) | 2005-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060178513-A1 | Pyridinylanilides | C3AR1, C5, PADI1 | HPGD 2195/4885CYP1A2 23/4885CYP2C19 51/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.